Discontinuation report APO-BRIMONIDINE
Report ID | 128438 |
Drug Identification Number | 02260077 |
Brand name | APO-BRIMONIDINE |
Common or Proper name | APO-BRIMONIDINE |
Company Name | APOTEX INC |
Market Status | DORMANT |
Active Ingredient(s) | BRIMONIDINE TARTRATE |
Strength(s) | 0.2% |
Dosage form(s) | SOLUTION |
Route of administration | OPHTHALMIC OPHTHALMIC |
Packaging size | 10mL and 5mL |
ATC code | S01EA |
ATC description | ANTIGLAUCOMA PREPARATIONS AND MIOTICS |
Reason for discontinuation | Business reasons |
Anticipated discontinuation date | |
Actual discontinuation date | 2020-04-17 |
Remaining supply date | 2020-04-17 |
Discontinuation status | Discontinued |
Discontinuation decision reversal | No |
Information on remaining supply | |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 150 SIGNET DRIVE TORONTO, ONTARIO CANADA M9L 1T9 |
Company contact information | Apotex Customer Service - 1-877-427-6839 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v1 | 2020-11-16 | English | Compare |
v2 | 2020-11-16 | French | Compare |
Showing 1 to 2 of 2